• Publications
  • Influence
Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society
These guidelines are intended for doctors who are engaged in the diagnosis and treatment of esophageal carcinoma to present the standard practice with a high regard for the principles of evidence-based medicine (EBM), and to improve the safety and results of treatment. Expand
For the clinical application of thermochemotherapy given at mild temperatures.
This paper summarizes the authors' own laboratory studies on the effect of chemotherapeutic agents given at elevated temperatures, experimental results obtained using animal tumour systems in other laboratories, and clinical trials of thermochemotherapy reported in literature. Expand
Guidelines for diagnosis and treatment of carcinoma of the esophagus
The results of this meta-analysis of randomized controlled trials performed in Europe and North America suggest that preoperative chemoradiotherapy combined with surgery has the potential to improve the long-term survival of patients undergoing surgical resection of esophageal carcinoma. Expand
Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
When total iodine dose was adjusted to body weight and injection duration was fixed, rapid administration of moderate concentration of Contrast material was more effective for depiction of hypervascular HCC than was high concentration of contrast material. Expand
Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma.
This study failed to demonstrate any possible benefit of accelerated hyperfractionation radiotherapy for malignant glioma or anaplastic astrocytoma, and the incidence of brain necrosis may be increased by combining acceleratedhyperfractionations radiotherapy and interferon-beta. Expand
Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer.
This two-step IMRT method as an adaptive RT scheme could adapt to changes in body contour, target volumes and risk organs during IMRT, and no patient complained of grade 2 or more xerostomia. Expand
Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology
Arm C was equally efficacious and exhibited a more favorable toxicity profile among three arms and should be considered a standard regimen in the management of locally advanced unresectable NSCLC. Expand
Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk
A PTV-margin of 5mm and a PRV- margin of 3mm is adopted for head and neck IMRT at the authors' department. Expand
Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients.
IORT yields an excellent local control rate for resected pancreatic cancer with few frequencies of severe late toxicity, and IORT combined with chemotherapy confers a survival benefit compared with that of IORT alone. Expand